Search the web
Welcome, Guest
[Sign Out, My Account]
Hoovers

Friday, October 24 2014 8:21am ET - U.S. Markets open in 1 hour and 9 minutes.
Industry Center
Industry Center > > Astellas Pharma Inc. Company Profile
More On This Industry
· Summary
· News
· Leaders & Laggards
· Company Index
·Industry Browser
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Need more? Get unbiased, in-depth information on public and private companies worldwide.
  
Astellas Pharma Inc. Company Profile
Astellas Pharma is a shining star in the Japanese pharmaceuticals market. One of the largest prescription drug companies in Japan, the company's main products include organ transplant immunosuppressant Prograf, overactive bladder treatment Vesicare, hypertension therapy Micardis, prostate enlargement treatment Harnal, and cholesterol drug Lipitor (sold in Japan via an agreement with Pfizer). Astellas' products (including those under development) include cardiovascular, central nervous system, oncology, metabolic, infectious disease, inflammation/immunology, gastroenterology, and urology therapies. The company markets its products to health care professionals and consumers in global markets.
Headlines for Astellas Pharma Inc.
Astellas Files for Amendment of Isavuconazole Study Protocol
- Fri Oct 17
Astellas' New Data on Cresemba for Invasive Mucormycosis
- Thu Oct 9
Saudi pharma firms urged to assess market positioning to ensure success
- Wed Oct 15
WomenHeart: The National Coalition for Women with Heart Disease Announces Class of 2014 WomenHeart Champions
- Wed 9:00 am ET
Contact Information
Address: 2-3-11 Nihonbashi-Honcho, Chuo-ku
Tokyo 103-8411, Japan
Phone:+81-3-3244-3000
Fax:+81-3-3244-3272
Financial Highlights
Fiscal Year End:March
Revenue (2014):11086.80 M
Revenue Growth (1 yr):3.90%
Employees (2014):17,649
Employee Growth (1 yr):1.10%
Key People
Chairman: Masafumi Nogimori
President and CEO: Yoshihiko Hatanaka
SVP and CFO: Yasumasa Masuda
Industry Information
Sector:
Industry:
Top Competitors
DAIICHI SANKYO COMPANY, LIMITED
Roche Holding Ltd (rhhby)
Takeda Pharmaceutical Company Limited
 


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2014, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?